TODAY'S HEADLINES
Add us to your address book or trusted sender list to help ensure delivery.

For the latest news, features, columns, video and audio reports and more, visit our home page at www.medpagetoday.com

Impaired Olfaction May Point to Impending Parkinson’s

HONOLULU -- One of the earliest signs of impending Parkinson’s disease could be right under a patient’s nose, according to a study here. full story

http://www.medpagetoday.com/Neurology/ParkinsonsDisease/tb/8853

Survey Time to ban imported drugs?

With the recent heparin troubles as a case in point, is it time to stop importing biologics? Vote

OTHER MEDPAGE TODAY EXTRAS

Blogs

Campaign '08

Multimedia

Practice Pointers

Campaign ’08: Party Line Divides Views on Healthcare Campaign Issues
BOSTON -- When push comes to shove in November, the perception of American excellence in healthcare delivery may well tip the scales for the presidency and the Congress, suggests a Harvard School of Public Health/Harris Interactive survey. full story

http://www.medpagetoday.com/PublicHealthPolicy/Campaign08/tb/8856

Gene Variants May Predict Osteoporosis in Whites

ROTTERDAM, The Netherlands -- The onset of reduced bone mineral density and increased fracture risk in whites may be intertwined with the presence of two common variants of a single gene, revealed a large multicenter study. full story

http://www.medpagetoday.com/Endocrinology/Osteoporosis/tb/8855

Liver Injury Linked to Darunavir (Prezista)
ROCKVILLE, Md. -- The anti-HIV drug darunavir (Prezista) may be associated with liver toxicity, the FDA and the drug’s maker warned today. full story

http://www.medpagetoday.com/InfectiousDisease/HIVAIDS/tb/8854

Rate of Decline in U.S. Tuberculosis Cases Has Slowed
ATLANTA -- Cases of tuberculosis continue to drop in the United States, but the rate of decline has slowed, according to the CDC. full story

http://www.medpagetoday.com/InfectiousDisease/Tuberculosis/tb/8852

Eye Movements Model Uhthoff’s Phenomenon in MS

DALLAS -- In an effort to understand Uhthoff’s phenomenon in multiple sclerosis, neurologists are using a special suit to cook and cool patients’ bodies to simulate the reversible heat-induced deterioration of function. full story

http://www.medpagetoday.com/Neurology/MultipleSclerosis/tb/8851

Chemotherapy for Colorectal Liver Metastasis May Improve Progression-Free Survival

BOULOGNE-BILLANCOURT, France -- Perioperative chemotherapy may improve progression-free survival for patients with resectable liver metastases from colorectal cancer, researchers found. full story

http://www.medpagetoday.com/HematologyOncology/ColonCancer/tb/8849

Serum Uric Acid May Herald Kidney Failure in Type 1 Diabetes

BOSTON -- For patients with type 1 diabetes, a serum uric acid concentration in the high-normal range may be an early signal of kidney failure, researchers here said. full story

http://www.medpagetoday.com/Endocrinology/Diabetes/tb/8848

Tocilizumab (Actemra) Found Effective in RA and Juvenile Idiopathic Arthritis

VIENNA, Austria -- For patients with rheumatoid arthritis or juvenile idiopathic arthritis, tocilizumab (Actemra), an investigational agent that blocks the interleukin-6 receptor, outperformed placebo in phase III trials. full story

http://www.medpagetoday.com/Rheumatology/Arthritis/tb/8847

New Lifetime Risk Estimates for Alzheimer’s and Dementia
BOSTON -- For women who reach age 55, the remaining lifetime risk of developing Alzheimer’s disease is 17%; for men it’s 9%, according to unpublished data from the Framingham Heart Study. full story

http://www.medpagetoday.com/Neurology/AlzheimersDisease/tb/8846

CME SPOTLIGHT

Evolution in the Use of Boosted PIs as First-line Therapy: Factors to Consider
Drs Graeme Moyle and Sharon Walmsley review studies that compare efficacy, safety, and metabolic parameters of PIs in head-to-head trials along with emerging data on drug-drug interactions and insulin resistance.
Source: AdvancMed [more]

The Quest for Erythropoiesis: A Preoperative Red Blood Cell Production
This Web activity, featuring experts in the field of blood management, provides a data-driven approach to the preoperative management of anemia in patients undergoing elective surgery.
Source: AdvancMed [more]

Optimizing the Care of Patients with Allergic Rhinitis: An Evidence-Based Approach to Diagnosis and Treatment
Approximately 20 to 40 million people in the US suffer from allergic rhinitis (AR). Many patients however, are undiagnosed. This CME/CE newsletter provides several tools to help simplify the diagnosis and treatment of AR.
Source: Med-IQ [more]

Managing the Symptomatic Menopausal Patient in Primary Care: A Case-Based Approach
This interactive CME activity provides practical recommendations and the latest clinical evidence to improve the personalized care a women receives during menopause.
Source: Interstate Postgraduate Medical Association and MEV Healthcom, Inc. [more]

Emerging Trends in the Treatment of Renal Cell Carcinoma
Drs. Michael B. Atkins, Bernard J. Escudier, and Gary R. Hudes lead this CME activity which examines current and evolving standards of care for the treatment of early stage and advanced renal cell carcinoma; best practices for optimal patient outcomes are also covered.
Source: The Physicians Academy For Clinical and Management Excellence [more]

Taking the Path of Least Resistance to Improved Clinical Outcomes from Surgical Site Infections
Join Dr. Sawyer for an innovative and in-depth CME-certified Activity on taking the path of least resistance to improve clinical outcomes from surgical site infections.
Source: CME Enterprise [more]

Bridging Cultural Differences to Improve HBV Treatment in Asian and Other Diverse Communities
This CME/CE program features state-of-the-science information on hepatitis B virus (HBV) disease burden, HBV replication and transmission, screening for HBV, treatment options and management of HBV.
Source: Projects In Knowledge [more]

New Frontiers in Targeted Therapy for Renal Cell Carcinoma
This activity is designed to educate clinicians on the most common malignancy of the kidney, renal cell carcinoma. Review evolving treatment strategies and best practices with Drs. Escudier, Eisen, and Rini.
Source: The Physicians Academy For Clinical and Management Excellence [more]

JOURNAL DOWNLOADS

First-line SUTENT® data recently published in NEJM
Read first-line SUTENT data in the New England Journal of Medicine. Get it at SUTENThcp.com Source: Pfizer [more]

Efficacy Data for CTCL Published in JCO
Efficacy Data for CTCL Published in JCO. Source: Merck. [more]

RESOURCES

Frequently painful. Potentially severe. Learn why your patients may be at risk.
Zoster: How Many of your patients are at risk? Source: Merck [more]

Explore the Possibilities in Type 2 Diabetes.
View efficacy studies: Type 2 diabetes efficacy research & 18 and 24-week study designs. Source: Merck [more]

Take a closer look at all 3 major lipids and cardiovascular risk. HDL, LDL and TG levels may be independently associated with cardiovascular risk.
Visit www.totallipids.com, a new source of information for health care professionals, about dyslipidemia, all 3 lipids, and cardiovascular risk. Source: Merck [more]

Access information on more than 150 Pfizer products at PfizerPro.com
Pfizer medicines have a new home on the Web. Visit PfizerPro.com for information on more than 150 Pfizer products. Convenient access to full prescribing information, scientific literature, professional resources, patient education material, and more. Source: Pfizer [more]